Sage Journals: Discover world-class research

Retricted access

Review article

First published 2023-4

Upadacitinib for the Treatment of Rheumatoid Arthritis: An Extensive Review

Eric G. Boyce, Edward L. Rogan, May C. Lui

Annals of Pharmacotherapy

Retricted access

Review article

First published 2014-12

A Review of Tofacitinib in the Treatment of Rheumatoid Arthritis and Psoriasis

Kristina A. Fanucci, David M. Rosmarin, Alice B. Gottlieb

Journal of Psoriasis and Psoriatic Arthritis®

Free access

Research article

First published 2010-10

Inhibition of the Signal Transducers and Activators of Transcription (STAT) 3 Signalling Pathway by AG490 in Laryngeal Carcinoma Cells

H Zhang, D Zhang, X Luan [...]

Journal of International Medical Research

Retricted access

Research article

First published 2024-11

Novel Management of Masticatory Myositis in Three Dogs with a Selective Janus Kinase (JAK-1) Inhibitor

Michael C. Congiusta, Christopher Snyder, Jason W. Soukup [...]

Journal of Veterinary Dentistry

Retricted access

Review article

First published 2019-5

The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature

Nicole Relke, Melinda Gooderham

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 1998-01

Structural and Mechanistic Aspects of Janus Kinases: How the Two-Faced God Wields a Double-Edged Sword

R.J. Duhé, W.L. Farrar

Journal of Interferon & Cytokine Research

Retricted access

Review article

First published 2025-9

A Review on the Mechanisms and Clinical Advances of JAK Inhibitors in the Treatment of Rosacea

Yulian Hu, Biyu Li, Runlu Hu [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Review article

First published 2019-5

The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature

Erika L. Crowley, Shamone C. Fine, Kathleen Kwan Katipunan [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Review article

First published 2023-10

Safety of Oral Janus Kinase Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis

Shanthi Narla, Jonathan I. Silverberg

Dermatitis®

Retricted access

Review article

First published 2021-12

Tofacitinib,the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis

Brittany N. Palasik, Hongmei Wang

Journal of Pharmacy Practice

Search results